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Abstract
Home blood pressure (HBP) monitoring is recommended for assessing the effects of 
antihypertensive treatment, but it is not clear how the treatment-induced changes in HBP compare 
with the changes in clinic BP (CBP). We searched PubMed using the terms “home or self-
measured blood pressure,” and selected articles in which the changes in CBP and HBP (using the 
upper arm oscillometric method) induced by antihypertensive drugs were presented. We 
performed a systematic review of 30 articles published before March 2008 that included a total of 
6794 subjects. As there was significant heterogeneity in most of the outcomes, a random effects 
model was used for the meta-analyses. The mean changes (± standard error) in CBP and HBP 
(systolic/diastolic) were -15.2±0.03/-10.3±0.03 mmHg and -12.2±0.04/-8.0±0.04 mmHg 
respectively, although there were wide varieties of differences in the reduction between HBP and 
CBP. The reductions in CBP were correlated with those of HBP (systolic BP; r=0.66, B=0.48, 
diastolic BP; r=0.71, B=0.52, P<0.001). In 7 studies that also included 24-hour BP monitoring, the 
reduction of HBP was greater than that of 24-hr BP in systolic (HBP; -12.6±0.06 mmHg, 24-hr 
BP; -11.9±0.04 mmHg, P<0.001). In 5 studies that included daytime and nighttime systolic BP 
separately, HBP decreased 15% more than daytime ambulatory BP and 30% more than nighttime 
ambulatory BP. In conclusion, HBP falls about 20% less than CBP with antihypertensive 
treatments. Daytime systolic BP falls 15% less and nighttime systolic BP falls 30% less than home 
systolic BP.
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The reduction of blood pressure (BP) levels by antihypertensive drug treatment is associated 
with decreased risks of cardiovascular events independently of the antihypertensive drug 
classes used to cause the reduction.1 In most of the studies investigating this effect BP has 
been evaluated using mercury or aneroid sphygmomanometers in a clinic or office setting. 
There is now increasing evidence that BP measurements made in “out-of-office” settings 
(using both home and ambulatory monitoring) are better predictors of cardiovascular 
events.2 The most widely used measure in these studies has been the twenty-four hour 
average ambulatory BP, which has been demonstrated to be a better predictor of 
cardiovascular events in patients taking antihypertensive medication.3 In a meta-analysis by 
Mancia and Parati,4 it was reported that the reduction of 24-hr average BP with 
antihypertensive medications (14.6 / 9.2 mmHg) was about 60 % of the reduction measured 
by clinic BP (24.9 / 14.5 mmHg).
Recently, devices for the self-measurement of home BP have become widely available, and 
their use for the evaluation of the effects of antihypertensive treatment has been endorsed by 
national and international guidelines,5-7 which recommend that BP should be measured both 
in the morning and at night. Like 24-hr ambulatory BP, home BPs also have greater 
predictive value for cardiovascular events than clinic BPs.8, 9 Home BP monitoring is less 
expensive and more suited to long-term repeated use than 24-hr ambulatory BP 
monitoring,10 and can assess the effectiveness of antihypertensive medication on BP control 
at different times of the day. Verberk et al.11 reported in the meta-analysis of home BP 
monitoring that the average reductions of clinic BP (20.1/13.6 mmHg) produced by 
antihypertensive medications were larger than the reductions of home BP (13.9/9.1 mmHg), 
but the number of studies available for this analysis was small (6 articles).
The purpose of this study was to compare, in a meta-analysis, the changes in home and 
clinic BP produced by different antihypertensive drugs, including the changes in both 
morning and evening BP levels.
Methods
Identification of papers
We performed a systematic review of home BP monitoring in PubMed at the end of 
December 2007. We used the key words “home blood pressure,” and “self-measured blood 
pressure” to search for candidate articles. Additional papers were collected from reference 
lists of the identified articles and reviews, and a follow-up search for more recent 
publications (through March 2008). There were no available articles in the Cochrane library.
Paper selection
A flow chart summarizing the paper selection process is shown in Figure 1.12-41 The full 
text of those papers identified as potentially relevant on the basis of their titles and abstracts 
was reviewed by 2 independent investigators (JI and DJC). The criteria for papers to be 
included in the present meta-analysis were as follows: (1) study evaluated the effect(s) of at 
least one antihypertensive drug therapy, (2) results published for both home BP and clinic 
Ishikawa et al. Page 2









BP, pre- and post-treatment, (3) home BP measured using a semiautomatic or automatic 
upper-arm cuff oscillometric device, and (4) home BP measured in the morning and/or 
evening according to the guidelines.5-7 Studies were excluded from our analysis if they 
included: (1) pregnant women, (2) children, (3) patients on hemodialysis, and (4) patients 
with severe arrhythmia. We included 2 articles in which home BPs were measured only in 
the morning31, 36 (the morning home BPs were used as the average home BPs in these 
studies) and one article where BP was measured in the morning, at noon, and in the 
evening.16 We included some articles in which the method of clinic BP measurements was 
not clearly described,15, 19, 24, 30, 31, 33, 35-37 and/or in which clinic BP was measured only 
once per clinic visit,31 but we repeated our analyses excluding these articles. Rater 
differences in the selection of articles were discussed, and the last author (TGP) resolved 
any remaining discrepancies concerning article eligibility.
Data extraction
The averages of age, percentage of males, body mass index, antihypertensive medication 
use, dose and timing of antihypertensive drugs, and the methods of clinic and home BP 
measurements for each study were all abstracted as background data. The levels and changes 
of the clinic and home BPs and their standard deviations (SD) during the antihypertensive 
treatment periods were also collected. One article40 published data only for mean BP and 
pulse pressure, but the systolic and diastolic BP could be obtained from the original 
database, because the first author of this meta-analysis was a co-author of the article. In 7 
articles,18, 20, 22, 25, 26, 32, 39 24-hr ambulatory BP data were also available, which we 
included in our analysis.
Data synthesis
The changes in clinic and home BPs were extracted for each of the eligible studies, 
excluding data for the placebo and control groups,14, 40 and also excluding 9 articles in 
which the method of clinic BP measurements were not described.15, 19, 24, 30, 31, 33, 35-37 The 
exclusion criteria of the 9 articles were as follows: 1) the technique and/or device of clinic 
BP measurements were not written, 2) the clinic BP was measured only once, and 3) the 
clinic BP was not measured by physicians or nurses. There were 13 articles in which home 
BP data were described separately for the morning and evening 
BP.12-15, 18, 20, 23, 25, 30, 37, 38, 40, 41 We also evaluated the changes in clinic, morning, and 
evening BP depending on whether the antihypertensive medication was taken in the 
morning12-15, 18, 20, 23, 25, 30, 41 or in the evening.12, 37, 38, 40 The effects of different 
antihypertensive drug classes on the changes in clinic and home BP (using morning dosing) 
were evaluated for calcium channel blockers (6 studies),12, 16, 17, 25, 35, 37 angiotensin 
converting enzyme inhibitors (5 studies),13, 14, 18, 21, 22 and angiotensin II receptor blockers 
(7 studies).18, 20-22, 24, 33, 41 Finally, we were able to compare the reductions of home BP 
with those of 24-hr BP in 7 articles18, 20, 22, 25, 26, 32, 39, and with daytime BP and nighttime 
BP in 5 articles. 22, 25, 26, 32, 39
Statistical analysis
The changes in BP measured before and after antihypertensive treatment periods are shown 
as mean ± standard error (SE), and the BPs measured at baseline are shown as mean ± SD. 
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In the data sets in which standard deviations after the treatment periods were unavailable, it 
was assumed that the SDs of the BP before and after treatment were the same. As most of 
the accepted articles did not show SDs of the changes in clinic and home BP, the SDs were 
calculated using the formula42: [(SD at baseline)2 + (SD at follow-up)2 − 2 r (SD at 
baseline) (SD at follow-up)](0.5) . The r values of changes in clinic and home BPs were 
estimated from a study in which all variables were available (i.e. clinic systolic BP 0.50, 
clinic diastolic BP 0.32, home systolic BP 0.56, home diastolic BP 0.75, morning systolic 
BP 0.61, morning diastolic BP 0.78, evening systolic BP 0.54, evening diastolic BP 0.72).40 
Before we evaluated the changes in clinic and home BP, we performed a heterogeneity test. 
The estimates of change in clinic and home BP exhibited significant heterogeneity across 
articles, and data synthesis was therefore performed using an unstandardized random effects 
model. Simple correlations between the reductions of BP were evaluated using Pearson's test 
weighted by the number of subjects enrolled in the studies. The differences in the change in 
clinic and home BP were calculated in all data sets, and meta-analyzed using a random 
effects model, except for the differences between home and 24-hr or daytime diastolic BP. 
These differences were analyzed using a fixed effects model because there was no 
significant heterogeneity. Additionally, the treatment induced BP changes corrected for the 
level of BP were calculated using the Oldham's correction43 (corrected BP change = actual 
change divided by the average of pre- and post-treatment BPs). The mean pre- and post-
treatment BPs were meta-analyzed using a random effects model. All statistical analyses 
were performed using Excel-based (Microsoft Corp. USA) meta-analysis worksheets 
(developed by JES and JI) and SPSS (version 14.0, SPSS Inc. Chicago, Illinois, USA).
Results
The methods of clinic and home BP measurements in the selected studies are shown in 
Table 1.12-41 The baseline characteristics in the selected studies are shown in the 
Supplemental Table (S1) (please see http://hyper.ahajournals.org). The baseline levels and 
treatment-induced reductions in clinic and home BP, and the antihypertensive medications 
used, are shown in Table 2. 12-41 The baseline levels and treatment-induced BP reductions 
including in morning and evening and 24-hr BP, and the details of antihypertensive 
medications in the selected studies are shown in the Supplemental Table (S2) (please see 
http://hyper.ahajournals.org). The changes in clinic and home BP are shown in Figure 2. The 
reductions of home BP (-12.2/-8.0 mmHg) were 20% less for systolic and 22% less for 
diastolic BP than the reductions of clinic BP (-15.2/-10.3 mmHg, P<0.001, N=6794). When 
we excluded data sets in which the methods of clinic BP measurement were not clearly 
described,15, 19, 24, 30, 31, 33, 35, 36 the reductions of clinic and home BP were similar: -14.7 ± 
0.04 / -10.7 ± 0.03 mmHg and -11.8 ± 0.04 / -8.1 ± 0.05 mmHg (P<0.001 for the both 
differences, N=6322). Scatter plots of the study-specific average changes in clinic and home 
systolic and diastolic BPs, and their correlations (weighted by the numbers of enrolled 
subjects) are shown in Figure 3. Additionally, scatter plots of study-specific average 
baseline BP levels and the BP reduction, and the correlations weighted by numbers of 
enrolled subjects are shown in Figure 4. The treatment induced BP changes corrected for the 
level of BP by using the Oldham's correction were 10.2 for clinic systolic BP, 11.5 % for 
clinic diastolic BP, 10.7 % for home systolic BP, and 9.2 % for home diastolic BP.
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In the 7 articles in which 24-hr average BPs were available (N=1246),18, 20, 22, 25, 26, 32, 39 
the changes in clinic, home, and 24-hr ambulatory BPs were -15.2 ± 0.07 / -10.2 ± 0.10 
mmHg, -12.6 ± 0.06 / -8.2 ± 0.07 mmHg, -11.9 ± 0.04 / -8.5 ± 0.02 mmHg, respectively, 
and the differences between home and 24-hr ambulatory systolic BP was significant (1.2 
mmHg, 95%CI 0.8-1.5 mmHg, P<0.001). Home systolic BP decreased 6% more than the 
24-hr average systolic BP. The reductions of home diastolic BP and 24-hr diastolic BP (8.2 
and 8.5 mmHg) were similar, although the difference was statistically significant (0.4 
mmHg, 95%CI 0.2 to 0.7 mmHg, P<0.001).
In the 5 articles in which both daytime BP and nighttime BP were separately available 
(N=801) (excluding 2 articles in which only 24-hr average BP data was 
available),22, 25, 26, 32, 39 the treatment-induced changes are shown in Figure 5. Thus home 
systolic BP decreased 15% more than daytime ambulatory systolic BP, and 30% more than 
nighttime ambulatory systolic BP. The differences in home and daytime BP reductions were 
1.6 mmHg (95%CI 1.1 to 2.2 mmHg, P<0.001) for systolic and 0.2 mmHg (95%CI -0.4 to 
0.8 mmHg, P=0.55) for diastolic, and that in home and nighttime BP reductions were 3.8 
mmHg (95%CI 3.3 to 4.4 mmHg, P<0.001) for systolic and 1.2 mmHg (95%CI 0.6 to 1.8 
mmHg, P<0.001) for diastolic. Additionally, the treatment induced BP changes corrected for 
the level of BPs by using the Oldham's correction were 10.3 % for clinic systolic BP, 10.9 % 
for clinic diastolic BP, 10.1 % for home systolic BP, 10.4 % for home diastolic BP, 8.5 % 
for daytime systolic BP, 9.0 % for daytime diastolic BP, 8.1 % for nighttime systolic BP, 
and 9.0 % for nighttime diastolic BP.
In the 10 articles in which antihypertensive drugs were taken in the morning 
(N=1809),12-15, 18, 20, 23, 25, 30, 41 the changes in clinic, morning and evening BP were -13.0 
± 0.04 / -11.2 ± 0.04 mmHg, -10.8 ± 0.08 / -6.1 ± 0.09 mmHg, -11.7 ± 0.06 / -7.4 ± 0.06 
mmHg. The evening BP was reduced marginally more than morning BP [the difference: 1.1 
mmHg (95%CI 0.9 to 1.2 mmHg, P<0.001) for systolic and 1.5 mmHg (95%CI 1.3 to 1.6 
mmHg, P<0.001) for diastolic]. In the 4 articles in which antihypertensive drugs were taken 
in the evening (N=399),12, 37, 38, 40 the changes in clinic, morning, and evening BP were 
-8.2 ± 0.07 / -5.0 ± 0.10 mmHg, -12.5 ± 0.17 / -7.5 ± 0.20 mmHg, -5.6 ± 0.12 / -3.8 ± 0.15 
mmHg. The morning BP reduced more than evening BP [the difference: 6.8 mmHg (95%CI 
6.57 to 6.95 mmHg, P<0.001) for systolic and 3.6 mmHg (95%CI 3.4 to 3.9 mmHg, 
P<0.001) for diastolic].
In 6 articles 121617, 253541, the effects of calcium channel blockers (taken in the morning) on 
the reduction of CBP and HBP were 17.5 ± 0.10 / 12.4 ± 0.13 mmHg and 14.1 ± 0.07 / 9.1 ± 
0.08 mmHg, and the differences between clinic and home BP were 3.3 mmHg (95%CI 3.1 
to 3.5 mmHg, P<0.001) for systolic and 3.0 mmHg (95%CI 2.8 to 3.3 mmHg). The BP 
reductions corrected for the level of BPs by using the Oldham's correction were 11.4 % for 
clinic systolic BP, 13.5 % for clinic diastolic BP, 9.5 % for home systolic BP, and 10.2 % 
for home diastolic BP. In 5 articles,13, 14, 18, 21, 22 the effects of angiotensin converting 
enzyme inhibitors on the reduction of clinic BP and home BP were 15.1 ± 0.07 / 10.9 ± 0.08 
mmHg and 11.9 ± 0.15 / 6.8 ± 0.14 mmHg, and the difference between clinic and home BP 
were 3.2 mmHg (95%CI 3.0 to 3.4 mmHg) for systolic and 4.3 mmHg (95%CI 3.7 to 4.9 
mmHg) for diastolic. The BP reductions corrected for the level of BPs by using the 
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Oldham's correction were 9.9 % for clinic systolic BP, 11.4 % for clinic diastolic BP, 8.4 % 
for home systolic BP, and 7.6 % for home diastolic BP. In 7 articles,18, 20, 22, 24, 33, 41 the 
effect of angiotensin II receptor blockers on reduction of CBP and HBP were 17.6 ± 0.07 / 
10.5 ± 0.11 mmHg and 9.9 ± 0.23 / 6.5 ± 0.14 mmHg, and the difference between clinic and 
home BP were 8.0 mmHg (95%CI 7.8 to 8.2 mmHg) for systolic and 3.2 mmHg (95%CI 2.7 
to 3.8 mmHg) for diastolic. The BP reductions corrected for the level of BPs by using the 
Oldham's correction were 14.3 % for clinic systolic BP, 11.2 % for clinic diastolic BP, 6.9 
% for home systolic BP, and 7.3 % for home diastolic BP. In 2 articles in which there were 
placebo or control subjects,14, 40 the changes in clinic and home BP were -4.5 ± 0.89 / -4.8 ± 
0.17 mmHg and -2.1 ± 0.32 / -1.9 ± 0.37 mmHg, respectively (the difference; both 
P<0.001).
Discussion
The main findings of the present meta-analyses are as follows: (1) the changes produced by 
antihypertensive drug treatments in home BP were 20% smaller than those of clinic BP, and 
the changes in clinic BP were linearly related to those of home BP; (2) the difference in the 
BP reduction between clinic and home BP were attributable to the difference in the baseline 
BP levels; (3) the changes in home SBP were intermediate between the changes of clinic and 
ambulatory SBPs (including 24-hr SBP, daytime SBP, and nighttime SBP); and (4) the 
differing effects on clinic and home BP were similar for calcium channel blockers, 
angiotensin converting enzyme inhibitors, and angiotensin II receptor blockers, and also for 
placebo or control groups.
The changes in clinic and home BP (systolic / diastolic) produced by antihypertensive drug 
treatments were -15.2 / -10.3 mmHg and -12.2 / -8.0 mmHg, respectively, and these 
reductions of BP were smaller than the values shown in the Verberk's previous meta-
analysis11. The changes in home and clinic BPs were linearly related to each other in the 
present meta-analysis, such that the effect on home BP was typically about 80% of the effect 
on clinic BP. Mancia and Parati4 reported that the reductions of clinic BP and 24-hr BP with 
antihypertensive treatments were -24.9 / -14.5 mmHg and -14.6 / -9.2 mmHg, respectively, 
and that the effect on 24-hr ambulatory BP was about 60% of the effect on clinic BP. Taken 
together, these results indicate that the reduction of home BP is about 20 % smaller, and that 
of 24-hr BP 40% smaller than the reduction of clinic BP produced by antihypertensive 
drugs.
The greater reductions of clinic BP than home BP with antihypertensive treatment were 
attributable to the difference in BP levels at baseline (usually clinic BP > home BP). This 
indicated that the lower the baseline BP levels are, the smaller the difference in the BP 
reduction between clinic BP and home BP will be.
In our meta-analysis of 7 studies which included 24-hr BP data as well as home 
BP,18, 20, 22, 25, 26, 32, 39 the reduction of 24-hr systolic BP was indeed less than the reduction 
of home SBP by 6%. When we analyzed the data in 5 studies in which both daytime and 
nighttime SBP were available, 22, 25, 26, 32, 39 the reductions of 24-hr systolic BP, daytime 
systolic BP and nighttime systolic BP were about 15%, 15% and 30% smaller than that of 
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home systolic BP. In the meta-analysis of Mancia and Parati,4 it was also reported that 
nighttime BP was reduced less than daytime BP by antihypertensive drugs taken in the 
morning. Our meta-analysis indicated that the reduction of daytime BP was smaller than that 
of home BP. The difficulties in reducing nighttime BP might derive from morning dosing of 
antihypertensive drugs. To obtain nighttime BP control, Kario et al.44 previously reported 
that nighttime dosing of doxazosin, an alpha-adrenergic blocker, is effective. Additionally, 
Hermida et al.45-47 have reported that angiotensin II receptor blockers taken at bedtime 
reduced nighttime BP significantly more than when taken in the morning.
It is not clear why home BP exhibits a smaller reduction than clinic BP and a greater 
reduction than 24-hr BP following antihypertensive drug treatment. The baseline levels of 
clinic BP were higher than home BP, and there might be a regression-to-the-mean effect. 
The regression line of baseline BP levels and the BP reduction were similar between clinic 
BP and home BP. Even in placebo or control groups, the reductions of clinic BP were larger 
than home BP. Additionally, there might be a white coat effect (transient BP elevation in the 
physician's office) which is generally recognized to be reduced by both active and placebo 
treatment.48 Another factor affecting the differences in the reductions of clinic and home BP 
seems to be the timing of the administration of antihypertensive medications. 
Antihypertensive drugs taken in the evening reduced morning BP greater than clinic BP.
In some trials the BP decline was larger at home than in the office; in other trials this 
difference was negligible, and in some the office BP decline was 3 times larger. These 
differences in the reductions of CBP and HBP might be explained by inaccuracy of CBP 
measurements, because some studies did not describe the technique of CBP measurements 
(i.e. the BP devices and number of measurements). Therefore, we analyzed the reductions of 
CBP and HBP after excluding data sets in which the methods of clinic BP measurement 
were not clearly described; however, the reductions of CBP and HBP were similar to the 
results of the whole data set.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The reduction of home BP produced by antihypertensive drug treatment is about 80% of 
the magnitude of the reduction of clinic BP.
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Figure 1. Flow chart of paper selection
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Figure 2. Changes in home and clinic blood pressures
Data were collected from 30 articles (6794 subjects), and analyzed using a random effects 
model. Data are shown as mean (standard error). CSBP indicates clinic systolic blood 
pressure; CDBP, clinic diastolic blood pressure; HSBP, home systolic blood pressure; 
HDBP, home diastolic blood pressure.
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Figure 3. Scatterplot of changes in between clinic and home blood pressures in all studies
Data were collected from 30 articles (6794 subjects). Regression line, correlation 
coefficients (r), and regression coefficients (B) were analyzed weighted for number of 
enrolled subjects. CSBP indicates clinic systolic blood pressure; CDBP, clinic diastolic 
blood pressure; HSBP, home systolic blood pressure; HDBP, home diastolic blood pressure.
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Figure 4. Relationship between baseline blood pressure levels and the reduction
Data were collected from 30 articles (6794 subjects). Regression line, correlation 
coefficients (r), and regression coefficients (B) were analyzed weighted for number of 
enrolled subjects. CSBP indicates clinic systolic blood pressure; CDBP, clinic diastolic 
blood pressure; HSBP, home systolic blood pressure; HDBP, home diastolic blood pressure.
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Figure 5. Changes in home and daytime and nighttime blood pressures
Data were collected from 5 articles (801 subjects), and analyzed using a random effects 
model except for the difference between home DBP and daytime DBP. Data are shown as 
mean (standard error). CSBP indicates clinic systolic blood pressure; CDBP, clinic diastolic 
blood pressure; HSBP, home systolic blood pressure; HDBP, home diastolic blood pressure. 
The difference between home BP and daytime BP are P<0.001 for systolic and P=0.59 for 
diastolic, and the difference between home BP and nighttime BP are both P<0.001
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